Get started
Author

Tatiana Verzhbitskaya

Observed names: N/ Yu. Verzhbitskaya, T Iu Verzhbitskaia, T. U. Verzhbitskaya, T. Verzhbitskaya, T. Yu. Verzhbitskaya, T.Y. Verzhbitskaya, T.Yu. Verzhbitskaya, Tatyana Verzhbitskaya, Вержбицкая Татьяна Юрьевна, Т Ю Вержбицкая, Т. Yu. Verzhbitskaya, Т. Ю. Вержбицкая
Observed institutions: Russian Cancer Research Center NN Blokhin, Ministry of Health of the Russian Federation, Institute of Medical Cell Technologies, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Regional Children's Clinical Hospital No. 1, Regional Children's Hospital No1
ORCID: 0000-0001-9329-1828
Observed ORCID: 0000-0001-9329-1828
OpenAlex ID: A5057494685
Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia
2019 · Alexander Popov, Guenter Henze, et al. · Journal of Cancer Research and Clinical Oncology · 44
Lineage Conversion in Pediatric B-Cell Precursor Acute Leukemia under Blinatumomab Therapy
2022 · Alexandra Semchenkova, Ekaterina Mikhailova, et al. · International Journal of Molecular Sciences · 39
PDF
Standardization of Flow Cytometric Minimal Residual Disease Monitoring in Children With B-cell Precursor Acute Lymphoblastic Leukemia. Russia–belarus Multicenter Group Experience
2016 · A. M. Popov, M. V. Belevtsev, et al. · Oncohematology · 32
Russian-belarusian Multicenter Group Standard Guidelines for Childhood Acute Lymphoblastic Leukemia Flow Cytometric Diagnostics
2018 · I. A. Novikova, T. Yu. Verzhbitskaya, et al. · Oncohematology · 30
PDF
Flow cytometry in acute leukemia diagnostics. Guidelines of Russian-Belarusian multicenter group for pediatric leukemia studies
2023 · A. M. Popov, T. Yu. Verzhbitskaya, et al. · Pediatric Hematology/Oncology and Immunopathology · 24
PDF
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022 · Alexander Popov, Guenter Henze, et al. · Leukemia · 18
Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma
2019 · Alexander Popov, Alexander Druy, et al. · Journal of Cancer Research and Clinical Oncology · 18
Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols
2020 · Alexander Popov, Barbara Buldini, et al. · Leukemia · 16
The influence of a dosage regimen of dexamethasone on detection of normal B-cell precursors in the bone marrow of children with BCP-ALL at the end of induction therapy
2020 · E. V. Mikhailova, T. Yu. Verzhbitskaya, et al. · Pediatric Hematology/Oncology and Immunopathology · 15
PDF
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022 · Alexander Popov, Guenter Henze, et al. · Journal of Cancer Research and Clinical Oncology · 14
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023 · Alexander Popov, Guenter Henze, et al. · Pediatric Blood & Cancer · 12
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol
2023 · Alexander Popov, Grigory Tsaur, et al. · Pediatric Blood & Cancer · 12
Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements
2021 · Alexander Popov, Grigory Tsaur, et al. · British Journal of Haematology · 12
Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report
2021 · Zhan Permikin, Alexander Popov, et al. · Leukemia Research · 11
Prognostic value of minimal residual disease measured by fusion‐gene transcript in infants with KMT2A‐rearranged acute lymphoblastic leukaemia treated according to the MLL‐Baby protocol
2021 · Grigory Tsaur, Alexander Popov, et al. · British Journal of Haematology · 11
PDF
Minimal residual disease monitoring in B-lineage acute lymphoblastic leukemia using flow cytometry. Guidelines of the Russian-Belarusian multicenter group for pediatric acute leukemia studies
2023 · A. M. Popov, E. V. Mikhailova, et al. · Pediatric Hematology/Oncology and Immunopathology · 9
PDF
Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype
2019 · Irina Demina, Elena Zerkalenkova, et al. · Journal of Cancer Research and Clinical Oncology · 9
Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial
2023 · Larisa Fechina, Alexander Popov, et al. · Leukemia · 8
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022 · Alexander Popov, Guenter Henze, et al. · Leukemia Research · 8
Acute Leukemias: Immunophenotypic Differences between Blast Cells and Their Nonneoplastic Analogues in Bone Marrow
2016 · Aleksandr Mikhailovich Popov, Т. Yu. Verzhbitskaya, et al. · Clinical oncohematology · 8
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008
2022 · Alexander Popov, Guenter Henze, et al. · Leukemia Research · 6
Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
2022 · A. Popov, G. Henze, et al. · Pediatric Hematology/Oncology and Immunopathology · 6
PDF
Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia
2021 · G. A. Tsaur, T. O. Riger, et al. · Pediatric Hematology/Oncology and Immunopathology · 6
PDF
[The limited possibility of using a simplified approach to detect minimal residual disease by the flow cytometry technique in children with precursor B-lineage acute lymphoblastic leukemia].
2011 · A M Popov, T Iu Verzhbitskaia, et al. · PubMed · 6
Incidence and prognostic value of central nervous system involvement in infants with B‐cell precursor acute lymphoblastic leukemia treated according to the MLL‐Baby protocol
2022 · Alexander Popov, Grigory Tsaur, et al. · Pediatric Blood & Cancer · 5
Works count: 77
Citation count: 439
H-index: 12
I10-index: 15
Year
Topic
Type